Binding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cells

Biochemical Journal

Volumn 366, Issue 1, 2002, Pages 137-144

  Maccarrone, Mauro ^a   Pauselli, Riccardo ^a   Di Rienzo, Marianna ^a   Finazzi Agrò, Alessandro ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Arachidonate cascade; Calcium; Endocannabinoids; Mitochondria; Nitric oxide

Indexed keywords

CALCIUM; DEGRADATION; ENZYMES; FATTY ACIDS;

APOPTOTIC ACTIVITY;

CELLS;

ADENYLATE CYCLASE; ARACHIDONIC ACID; CALCIUM; CANNABINOID; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CYCLIC AMP; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; STEAROYLETHANOLAMIDE; UNCLASSIFIED DRUG; VANILLOID RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; DRUG ACTIVITY; DRUG BINDING; DRUG DEGRADATION; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; DRUG UPTAKE; GLIOMA CELL; HYDROLYSIS; ISOTOPE LABELING; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; ARACHIDONIC ACIDS; CALCIUM; CANNABINOIDS; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCANNABINOIDS; HYDROLYSIS; KINETICS; MITOCHONDRIA; MODELS, BIOLOGICAL; NITRIC OXIDE; POLYUNSATURATED ALKAMIDES; PROTEIN BINDING; RATS; STEARIC ACIDS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0037103724     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20020438     Document Type: Article

References (42)

1. 2-Arachidonoylglycerol and the cannabinoid receptors
2. 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor
3. Cellular signal transduction by anandamide and 2-arachidonoylglycerol
4. Comparative biology of the endocannabinoid system. Possible role in the immune response
5. Endocannabinoids as cardiovascular modulators
6. The palmitoylethanolamide and oleamide enigmas: Are these two fatty acid amides cannabimimetic?
7. An anorexic lipid mediator regulated by feeding
8. Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain
9. Anandamide degradation and N-acylethanolamines level in wild-type and CB1 cannabinoid receptor knockout mice of different ages
10. + cells
11. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice
12. Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors
13. Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation
14. Anandamide induces apoptosis of PC-12 cells: Involvement of superoxide and caspase-3
15. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
16. Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens
17. Anandamide uptake by human endothelial cells and its regulation by nitric oxide
18. The peripheral cannabinoid receptor: Adenylate cyclase inhibition and G protein coupling
19. + exchanger NHE-1 isoform via Gi-mediated mitogen activated protein kinase signaling transduction pathways
20. The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes
21. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death
22. Intracellular heterogeneity in mitochondrial membrane potential revealed by J-aggregate-forming lipophilic cation JC-1
23. Flow cytometric measurement of cytoplasmic free calcium in human peripheral blood T lymphocytes with fluo-3, a new fluorescent calcium indicator
24. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: Inhibitors of anandamide uptake with negligible capsaicin-like activity
25. Pharmacology of cannabinoid CB1 and CB2 receptors
26. The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: Connections with anandamide
27. Structural determinants for recognition and translocation by the anandamide transporter
28. The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism
29. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist
30. The fatty acid amide hydrolase (FAAH)
31. The CB1 cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase
32. Lipoxygenases and their involvement in programmed cell death
33. Prostaglandins and leukotrienes: Advances in eicosanoid biology
34. Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase
35. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain
36. A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid
37. Selective cannabinoid CB1 receptor-mediated inhibition of inducible nitric oxide synthase protein expression in C6 rat glioma cells
38. An entourage effect: Inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity
39. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells
40. Characterization and manipulation of the acyl chain selectivity of fatty acid amide hydrolase
41. 9-tetrahydrocannabinol
42. A function for lipoxygenase in programmed organelle degradation